Chang-Han Lee

7PUBLICATIONS
41CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Industrial and organisational psychology (incl. human factors)Molecular targetsMolecular, biological, and multi-scale communicationsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 29, 2026
KRAS Mutations Reprogram RNA m6A Modifications to Drive CD73-Dependent Immune Evasion in Colorectal Cancer.

|Jun 28, 2026
What KJPP looks for: guidance from initial editorial screening.

|Apr 10, 2026
Rapid CAR screening and circRNA-driven CAR-NK cells for persistent shed-resistant immunotherapy.

Joo-Yoon Chung, Jisu Hong, Su-Min Yee

|Jan 14, 2026
Dual Targeting of Tau Kinases and Autophagy by Abemaciclib Independent of CDK4/6 Inhibition.

Jihui Han, June-Hyun Jeong, Dongjoon Lee

|Nov 27, 2019
Publisher Correction: An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence.

Chang-Han Lee, Tae Hyun Kang, Ophélie Godon

|Nov 08, 2019
An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence.

Chang-Han Lee, Tae Hyun Kang, Ophélie Godon

Pageof 2

Frequent Collaborators

2 joint publications

Tae Hyun Kang

2 joint publications

Makiko Watanabe

2 joint publications

George Delidakis

2 joint publications

Caitlin M Gillis